483 Livzon Group (Ningxia) Pharmaceutical Dec 2019

483 Livzon Group (Ningxia) Pharmaceutical Dec 2019

Jose Cayuela FDA, Vincent Thomas FDA$119.00 - Available Now

FDA investigators audited the Livzon Group (Ningxia) Pharmaceutical - Shizuishan, China facility and issued inspectional observations (via FDA 483) on 06 Dec 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 06 Dec 2019
  • Location: Shizuishan, China
  • FEI: 3012375554
Add To Cart